EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Uncovering the structural impact of KatG Ser315 mutations in Mycobacterium tuberculosis via cryo‐ EM

Thomas Allport, Amanda K Chaplin iD

Protein Science · 2026

DOI: 10.1002/pro.70409 ↗

At a glance

Journal article in Protein Science, 2026. Written by Thomas Allport and 1 co-authors. Institution: Department of Molecular and Cell Biology, University of Leicester, Leicester Institute for Structural and Chemical Biology, Leicester, UK. Major MEDLINE topics: Mycobacterium tuberculosis, Bacterial Proteins, Catalase. 37 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Mycobacterium tuberculosis ( Mtb ), the causative agent of tuberculosis (TB), is responsible for a global health burden affecting over a quarter of the world's population. The increasing prevalence of drug‐resistant TB poses a significant threat to current treatment strategies. Isoniazid (INH) is a first‐line prodrug used in TB therapy, which requires activation by the catalase‐peroxidase enzyme KatG. Upon activation, INH inhibits InhA, thereby disrupting mycolic acid biosynthesis, a crucial process for maintaining Mtb 's distinctive, lipid‐rich cell wall. The most common naturally occurring resistance‐associated mutation in KatG is S315T, though other variants at this position, such as S315G, S315N, S315I, and S315R, have also been reported. In this study, we employ cryo‐electron microscopy (cryo‐EM) to investigate the structural basis of INH resistance conferred by these KatG variants. We present high‐resolution cryo‐EM structures that reveal heterogeneity in heme loading among the mutants. Detailed structural analysis highlights alterations in the hydrogen‐bonding network and substrate access channel unique to each variant, offering direct comparisons with the wild‐type (WT) KatG protein. Our findings provide a molecular explanation for clinical INH resistance and lay the groundwork for the rational design of next‐generation anti‐TB therapeutics.

Subjects

MeSH terms (MEDLINE)

Mycobacterium tuberculosisBacterial ProteinsCatalaseCryoelectron MicroscopyIsoniazidDrug Resistance, BacterialMutationAntitubercular AgentsModels, Molecular

Author keywords

KatGcatalasecryo‐EMhemeperoxidase

Substances

Bacterial ProteinsCatalasekatG protein, Mycobacterium tuberculosisIsoniazidAntitubercular Agents

Authors and institutions

  • Department of Molecular and Cell Biology, University of Leicester, Leicester Institute for Structural and Chemical Biology, Leicester, UK.

ORCID profiles: Amanda K Chaplin

Cite

APA

Allport, T., & Chaplin, A. K. (2026). Uncovering the structural impact of KatG Ser315 mutations in Mycobacterium tuberculosis via cryo‐ EM. Protein Science. https://doi.org/10.1002/pro.70409

Vancouver

Allport T, Chaplin AK. Uncovering the structural impact of KatG Ser315 mutations in Mycobacterium tuberculosis via cryo‐ EM. Protein Science. 2026. doi:10.1002/pro.70409

BibTeX
@article{Allport2026,
  author = {Allport, Thomas and Chaplin, Amanda K},
  title = {Uncovering the structural impact of KatG Ser315 mutations in Mycobacterium tuberculosis via cryo‐ EM},
  journal = {Protein Science},
  year = {2026},
  doi = {10.1002/pro.70409}
}
Start for free →